WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 1191

Legislative bill overview

SB 1191 would establish a state-administered program in Connecticut to screen for pancreatic cancer and refer patients to appropriate treatment facilities. The bill creates a formal mechanism for early detection and care coordination, though the specific screening criteria, funding mechanisms, and implementation details are not provided in the legislative summary.

Why is this important

Pancreatic cancer has one of the lowest survival rates among cancers, with early detection significantly improving outcomes. A structured screening and referral program could improve survival rates and reduce treatment costs by catching cases earlier, while also standardizing care pathways across the state.

Potential points of contention

  • Cost and funding: The bill's fiscal impact remains unclear—who bears the cost of screening (patients, insurance, state budget) and whether appropriations are sufficient could generate substantial debate
  • Screening criteria and eligibility: Determining who qualifies for screening (high-risk populations vs. general public) involves medical, ethical, and equity considerations that may be contentious
  • Operational feasibility: Establishing infrastructure for statewide screening coordination and ensuring adequate participation from treatment facilities and healthcare providers poses logistical challenges

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.